FDA Adverse Event Injury Summary report: N

FARAWAVE

MDR report key: 21601954 · Received March 13, 2025

Report

Report Number
2124215-2025-15891
Event Type
Injury
Date Received
March 13, 2025
Date of Event
February 25, 2025
Report Date
June 12, 2025
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
QZI
UDI-DI
00191506043148
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CORRECTION TO SECTION H6 PATIENT CODES, CODE E060101 WAS ADDED. DETAILED PRODUCT INFORMATION WAS NOT PROVIDED TO BSC. IT WAS NOT AVAILABLE BECAUSE THE DEVICE WAS DISCARDED. BECAUSE THE PRODUCT IS UNKNOWN, WE ARE UNABLE TO PROVIDE THE UNIQUE IDENTIFIER (UDI) AND OTHER SPECIFIC PRODUCT INFORMATION. IT WAS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION. IF THERE IS ANY FURTHER RELEVANT INFORMATION OBTAINED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Additional Manufacturer Narrative · 0

IT WAS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION. IF THERE IS ANY FURTHER RELEVANT INFORMATION OBTAINED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION WAS PROVIDED IN SECTION B5 DESCRIBE EVENT OR PROBLEM DETAILED PRODUCT INFORMATION WAS NOT PROVIDED TO BSC. IT WAS NOT AVAILABLE BECAUSE THE DEVICE WAS DISCARDED. BECAUSE THE PRODUCT IS UNKNOWN, WE ARE UNABLE TO PROVIDE THE UNIQUE IDENTIFIER (UDI) AND OTHER SPECIFIC PRODUCT INFORMATION. IT WAS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION. IF THERE IS ANY FURTHER RELEVANT INFORMATION OBTAINED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT EXPERIENCED ATRIAL FIBRILLATION. THE PHYSICIAN HAD COMPLETED A PULMONARY VEIN ISOLATION AND POSTERIOR WALL ABLATION WITH A FARAWAVE PULSED FIELD ABLATION (PFA) CATHETER. ONCE THE PROCEDURE WAS COMPLETED, THE PATIENT WAS STILL IN ATRIAL FIBRILLATION, THEREFORE THE PHYSICIAN DECIDED TO CARDIOVERT THE PATIENT. A SYNCHRONIZED SHOCK WAS PERFORMED AT 360 JOULE SHOCK. UPON COMPLETION, THE PATIENT HAD NO UNDERLYING RHYTHM. PERCUTANEOUS PACING WAS PERFORMED FOR 40 MINUTES WITH CHECKS EVERY 5 MINUTES TO SEE IF THERE WAS A RHYTHM. NO UNDERLYING RHYTHM BECAME PRESENT. A PERMANENT PACEMAKER WAS PLACED IMMEDIATELY FOLLOWING PROCEDURE. THE PHYSICIAN DOES NOT BELIEVE PFA WAS THE CAUSE BUT WOULD LIKE A FOLLOW UP. THE PATIENT IS EXPECTED TO FULLY RECOVER. THE CATHETER IS NOT EXPECTED TO RETURN AS IT WAS DISPOSED THEREFORE THE LOT NUMBER IS NOT AVAILABLE.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT EXPERIENCED ATRIAL FIBRILLATION. THE PHYSICIAN HAD COMPLETED A PULMONARY VEIN ISOLATION AND POSTERIOR WALL ABLATION WITH A FARAWAVE PULSED FIELD ABLATION (PFA) CATHETER. ONCE THE PROCEDURE WAS COMPLETED, THE PATIENT WAS STILL IN ATRIAL FIBRILLATION, THEREFORE THE PHYSICIAN DECIDED TO CARDIOVERT THE PATIENT. A SYNCHRONIZED SHOCK WAS PERFORMED AT 360 JOULE SHOCK. UPON COMPLETION, THE PATIENT HAD NO UNDERLYING RHYTHM. PERCUTANEOUS PACING WAS PERFORMED FOR 40 MINUTES WITH CHECKS EVERY 5 MINUTES TO SEE IF THERE WAS A RHYTHM. NO UNDERLYING RHYTHM BECAME PRESENT. A PERMANENT PACEMAKER WAS PLACED IMMEDIATELY FOLLOWING PROCEDURE. THE PHYSICIAN DOES NOT BELIEVE PFA WAS THE CAUSE BUT WOULD LIKE A FOLLOW UP. THE PATIENT IS EXPECTED TO FULLY RECOVER. THE CATHETER IS NOT EXPECTED TO RETURN AS IT WAS DISPOSED THEREFORE THE LOT NUMBER IS NOT AVAILABLE.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT EXPERIENCED ATRIAL FIBRILLATION. THE PHYSICIAN HAD COMPLETED A PULMONARY VEIN ISOLATION AND POSTERIOR WALL ABLATION WITH A FARAWAVE PULSED FIELD ABLATION (PFA) CATHETER. ONCE THE PROCEDURE WAS COMPLETED, THE PATIENT WAS STILL IN ATRIAL FIBRILLATION, THEREFORE THE PHYSICIAN DECIDED TO CARDIOVERT THE PATIENT. A SYNCHRONIZED SHOCK WAS PERFORMED AT 360 JOULE SHOCK. UPON COMPLETION, THE PATIENT HAD NO UNDERLYING RHYTHM. PERCUTANEOUS PACING WAS PERFORMED FOR 40 MINUTES WITH CHECKS EVERY 5 MINUTES TO SEE IF THERE WAS A RHYTHM. NO UNDERLYING RHYTHM BECAME PRESENT. A PERMANENT PACEMAKER WAS PLACED IMMEDIATELY FOLLOWING PROCEDURE. THE PHYSICIAN DOES NOT BELIEVE PFA WAS THE CAUSE BUT WOULD LIKE A FOLLOW UP. THE PATIENT IS EXPECTED TO FULLY RECOVER. THE CATHETER IS NOT EXPECTED TO RETURN AS IT WAS DISPOSED THEREFORE THE LOT NUMBER IS NOT AVAILABLE. IT WAS FURTHER CONFIRMED THAT THE PATIENT HAD SINUS ARREST AND THE PATIENT WAS PERSISTENT ATRIAL FIBRILLATION FOR APPROXIMATELY 2 YEARS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1331456 FARAWAVE CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER QZI BOSTON SCIENTIFIC CORPORATION 00191506043148

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention| O